Post by Syed Al Refaie
Founder & CEO at Viellis & NeuroSync Technologies
#Neurolog #brain #HIMSS2026 #BrainMachineInterfaces #BCI #PBM #fNIRS #JPM2026 #NonInvasiveNeuronalSignals #mentalhealth #rTMS #mentaldisorders #Autisim #Neuroprosthetics #neurotechnology #NiBS #Neuralink #brainsignals #ADHD #Alzheimer #Depression #Anxiety #Dementia #electroencephalogram #Parkinson’s #Neurology #DBS #VR #BrainMachineInterfaces #neuroscience #neurobiology #treatment #neurodegeneration #brainresearch #clinicalresearch #alzheimer #eyes #neurologicaldisorders #biomarker #precisionmedicine #therapy #neurodegenerativediseases #neuromodulation #neuronavigation #complexnetworks #systemstheory #neurosergen #synapticpasticity #clinicaldevelopment #brainfunction #INVASIVE #Noninvasive #sensors #medicalinnovation #hlth2026 #wearabletechnology #smartsensors #digitalinclusion #Innovation #bpm #BrainStimulation #CES2026 #blindness #VisualImpairment #Glaucoma #xerophthalmia #Cataracts #retinoblastoma #Davos2026 #brain2brain #BrainVR #ultrasound
Video Content